Tozasertib

Overview

Tozasertib (VX 680; MK-0457) is an inhibitor of Aurora A/B/C kinases with K i s of 0.6, 18, 4.6 nM, respectively.

Application

Products | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Autophagy | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Aurora Kinase | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-10161
• CAS No.: 639089-54-6
• Molecular Formula: C23H28N8OS
• Molecular Weight: 464.59
• Purity: 99.92%
• Storage: 4°C, protect from light * In solvent : -80°C, 1 year; -20°C, 6 months (protect from light)
• Solubility: ≥ 2.08 mg/mL (4.48 mM); Clear solution
• Availability: In-stock

Source

Original product source